Department of Intensive Care Unit, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Chin Med J (Engl). 2012 Mar;125(5):828-31.
Encephalopathy is a common complication of sepsis, and its onset can occur at any stage of sepsis and implies worse prognosis. However, the incidence, epidemiology, and pathogenesis of sepsis-associated encephalopathy remain controversial. The purpose of this study was to investigate the epidemiological features and risk factors for sepsis-associated encephalopathy.
Our retrospective study included all patients with sepsis admitted to our intensive care unit from 2008 to 2011. After excluding 91 patients, 232 patients were assigned to either a sepsis-associated encephalopathy group or sepsis without encephalopathy group. Between-group differences in baseline patient data including vital signs, disease severity, pathogens, sites of infection, biochemical indicators, and time on a mechanical ventilator, intensive care unit (ICU) stay, and 28-day mortality rate were analyzed.
The incidence of sepsis-associated encephalopathy was 17.7%. The sepsis-associated encephalopathy group had significantly higher 28-day mortality (56.1% vs. 35.1%; P=0.013), spent a significantly longer time on a ventilator ((8.2±2.2) days vs. (2.9±0.4) days; P=0.021), and had a significantly longer ICU stay ((12.4±2.4) days vs. (7.1±0.6) days; P=0.042). Acute physiology and chronic health evaluation II score, Glasgow coma scale, heart rate, blood lactate, serum sodium, platelets, serum albumin, and pH values were related to the presence of encephalopathy. Patients with biliary tract infections and intestinal infections caused by Staphylococcus aureus, Enterococcus faecium, Acinetobacter spp, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia, were more prone to develop sepsis-associated encephalopathy.
Encephalopathy increases mortality rate in septic patients. Clinical intervention to reduce risk factors and thereby morbidity and mortality depends on a correct understanding of the differences between patients with sepsis and patients with both sepsis and encephalopathy.
脑病是脓毒症的常见并发症,其发病可发生在脓毒症的任何阶段,并提示预后更差。然而,脓毒症相关性脑病的发病率、流行病学和发病机制仍存在争议。本研究旨在探讨脓毒症相关性脑病的流行病学特征和危险因素。
我们的回顾性研究纳入了 2008 年至 2011 年期间入住我院重症监护病房的所有脓毒症患者。排除 91 例患者后,将 232 例患者分为脓毒症相关性脑病组和无脑病脓毒症组。分析两组患者的基本资料差异,包括生命体征、疾病严重程度、病原体、感染部位、生化指标以及机械通气时间、重症监护病房(ICU)住院时间和 28 天死亡率。
脓毒症相关性脑病的发病率为 17.7%。脓毒症相关性脑病组 28 天死亡率明显较高(56.1%比 35.1%;P=0.013),呼吸机使用时间明显较长[(8.2±2.2)天比(2.9±0.4)天;P=0.021],ICU 住院时间明显较长[(12.4±2.4)天比(7.1±0.6)天;P=0.042]。急性生理学和慢性健康评估Ⅱ评分、格拉斯哥昏迷评分、心率、血乳酸、血清钠、血小板、血清白蛋白和 pH 值与脑病的发生有关。胆道感染和金黄色葡萄球菌、屎肠球菌、不动杆菌属、铜绿假单胞菌和嗜麦芽窄食单胞菌引起的肠道感染患者更易发生脓毒症相关性脑病。
脑病增加了脓毒症患者的死亡率。通过临床干预减少危险因素,从而降低发病率和死亡率,取决于对脓毒症患者和同时患有脓毒症和脑病患者之间差异的正确认识。